Published in J Clin Endocrinol Metab on July 01, 2002
Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. Biol Reprod (2008) 1.22
Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol (2007) 1.06
Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women. Fertil Steril (2009) 1.04
Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril (2007) 1.04
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med (2015) 0.99
Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril (2011) 0.96
Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab (2012) 0.95
The emerging use of aromatase inhibitors for endometriosis treatment. Reprod Biol Endocrinol (2011) 0.90
Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod Sci (2011) 0.89
Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis. Am J Pathol (2015) 0.85
Aromatase inhibitors for the treatment of endometriosis. Fertil Steril (2012) 0.85
Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol (2007) 0.81
Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model. J Assist Reprod Genet (2014) 0.80
Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons. Fertil Steril (2012) 0.79
Mouse model of surgically-induced endometriosis by auto-transplantation of uterine tissue. J Vis Exp (2012) 0.78
Cyclooxygenase-2 inhibitors in gynecologic practice. Clin Med Res (2003) 0.78
A low-testosterone state associated with endometrioma leads to the apoptosis of granulosa cells. PLoS One (2014) 0.77
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev (2005) 2.44
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev (2013) 1.91
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy. Cancer (2005) 1.69
Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab (2008) 1.41
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril (2004) 1.40
Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod (2008) 1.39
Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res (2009) 1.39
Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology (2010) 1.36
Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. J Clin Endocrinol Metab (2007) 1.35
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 1.35
Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod (2007) 1.34
Setting research priorities to reduce mortality and morbidity of childhood diarrhoeal disease in the next 15 years. PLoS Med (2013) 1.34
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res (2007) 1.33
Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res (2003) 1.28
High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab (2009) 1.26
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril (2007) 1.25
Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril (2005) 1.24
Steroid receptor and aromatase expression in baboon endometriotic lesions. Fertil Steril (2003) 1.20
Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci (2002) 1.18
Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest (2008) 1.16
A modified baboon model for endometriosis. Ann N Y Acad Sci (2002) 1.14
Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril (2006) 1.14
Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol (2005) 1.12
Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab (2002) 1.11
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts. Cancer Res (2007) 1.11
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med (2003) 1.10
Regulation of breast cancer-associated aromatase promoters. Cancer Lett (2008) 1.10
Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod (2009) 1.09
Treatment of diarrhea in young children: results from surveys on the perception and use of oral rehydration solutions, antibiotics, and other therapies in India and Kenya. J Glob Health (2013) 1.08
Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. J Clin Endocrinol Metab (2008) 1.08
Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol (2007) 1.06
Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am (2006) 1.05
Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS One (2012) 1.05
WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. J Clin Endocrinol Metab (2002) 1.04
Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res (2010) 1.03
A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem (2005) 1.03
Role of stem cells in human uterine leiomyoma growth. PLoS One (2012) 1.02
Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab (2002) 1.02
Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab (2007) 1.02
Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol (2007) 1.02
Steroidogenic factor-1 and endometriosis. Mol Cell Endocrinol (2008) 1.01
WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells. Mol Cell Endocrinol (2003) 1.00
CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity. Mol Cell Endocrinol (2007) 1.00
Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis. Fertil Steril (2004) 0.99
Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. PLoS One (2012) 0.99
SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol Reprod (2006) 0.99
The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression. Proc Natl Acad Sci U S A (2010) 0.99
Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J Clin Endocrinol Metab (2008) 0.99
Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A (2013) 0.98
Prevalence of primary dysmenorrhea in young adult female university students. Arch Gynecol Obstet (2008) 0.97
Global action plan for childhood diarrhoea: Developing research priorities: Report from a Workshop of the Programme for Global Paediatric Research. J Glob Health (2013) 0.96
Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril (2011) 0.96
Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol (2002) 0.96
BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells. J Clin Endocrinol Metab (2006) 0.95
Aromatase and endometriosis. Semin Reprod Med (2004) 0.94
Altered retinoid uptake and action contributes to cell survival in endometriosis. J Clin Endocrinol Metab (2010) 0.93
Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene. Reprod Sci (2008) 0.93
Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. J Clin Endocrinol Metab (2007) 0.92
A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue. Reprod Biol Endocrinol (2009) 0.92
Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res (2005) 0.92
The efficacy of venlafaxine in the treatment of women with stress urinary incontinence. Arch Gynecol Obstet (2008) 0.92
Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet (2007) 0.92
Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol Endocrinol (2002) 0.91
Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. J Mol Endocrinol (2011) 0.90
Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression. J Nucl Med (2009) 0.90
Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. Am J Obstet Gynecol (2009) 0.90
Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. Hum Reprod (2011) 0.90
Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Am J Obstet Gynecol (2007) 0.90
A call for more transparency of registered clinical trials on endometriosis. Hum Reprod (2009) 0.89
Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod Sci (2011) 0.89
Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation. J Clin Endocrinol Metab (2013) 0.89
Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells. J Clin Endocrinol Metab (2009) 0.89
Aromatase promoter I.f is regulated by estrogen receptor alpha (ESR1) in mouse hypothalamic neuronal cell lines. Biol Reprod (2009) 0.89
Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation (2004) 0.88
Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Clin Cancer Res (2006) 0.88
Regulation of 17-beta hydroxysteroid dehydrogenase type 2 in human placental endothelial cells. Biol Reprod (2007) 0.87
Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer. Lung Cancer (2011) 0.87
Safe techniques in surgery for hysteroscopic myomectomy. J Obstet Gynaecol Res (2005) 0.87
The effect of hysterectomy and bilaterally salpingo-oophorectomy on sexual function in post-menopausal women. Maturitas (2008) 0.87
CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab (2008) 0.86